Instrument Inactif

Communiqués Sigma-Aldrich Corporation

Actions

US8265521018

Chimie de spécialité

Cours en clôture Nasdaq Autres places de cotation
- ^USD	-

06/08/15	Merck KGaA : La reprise d'AZ a soutenu les résultats de Merck KGaA	RE
06/08/15	Merck KGaA : La reprise d'AZ a soutenu les résultats de Merck KGaA	RE

Communiqués

10/11/15	Sigma Aldrich : and Merck KGaA, Darmstadt, Germany, Obtain EC Antitrust Approval and Work Toward Closing Planned Acquisition	PR
04/11/15	Sigma Aldrich : Collaborates with GENEWIZ and Oxford Genetics to Speed Ordering Process for DNA Services	PR
03/11/15	Sigma Aldrich : NASDAQ - SIAL) Reports Q3 2015 Sales Of $703 Million And Adjusted Diluted EPS Of $1.00	PR
29/10/15	Sigma Aldrich : Acquires Duolink Product Portfolio from Olink Bioscience	PR
27/10/15	Sigma Aldrich : Announces Strategic Collaboration with UC San Francisco's Catalyst Program to Accelerate Commercialization of Innovative Research Tools	PR
20/10/15	Sigma Aldrich : Announces Agreement on Assets Sale to Honeywell to Fulfill EU Commitments	PR
19/10/15	Sigma Aldrich : Partners with Sanger Institute on First Arrayed Whole Genome Lentiviral CRISPR Libraries	PR
08/10/15	Sigma Aldrich : Cerilliant Introduces Certified Spiking Solutions of Bile Acids	PR
28/09/15	Sigma Aldrich : and Merck KGaA, Darmstadt, Germany, Making Progress Toward Completion of Planned Acquisition	PR
22/09/15	Sigma Aldrich : Named to Dow Jones Sustainability Indices	PR
17/09/15	Sigma Aldrich : Announces Exclusive Distribution Agreement with IROA Technologies, LLC	PR
15/09/15	Sigma Aldrich : Cerilliant Introduces New Multi-Component Reference Solutions for Drug Interference Testing	PR
27/08/15	Sigma Aldrich : Announces Agreement with Public Health England to Manufacture and Supply NCTC/NCPF Certified Reference Materials	PR
25/08/15	Sigma Aldrich : Declares Quarterly Dividend	PR
11/08/15	Sigma Aldrich : and Merck KGaA, Darmstadt, Germany, Obtain Antitrust Approval in Brazil for Planned Acquisition	PR
30/07/15	Sigma Aldrich : NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01	PR
23/07/15	Sigma Aldrich : Meets Evolving Quality and Regulatory Needs with ISO 13485 Expansion, Provides Diagnostic Customers with Reliable Critical Raw Materials	PU
15/06/15	Sigma Aldrich : Acquisition of Sigma-Aldrich by Merck KGaA, Darmstadt, Germany, Receives Approval from European Union Regulators and from Chinese Ministry of Commerce	PR
11/06/15	Sigma Aldrich : ® Named to Newsweek's 2015 Green Rankings	PR
09/06/15	Sigma Aldrich : Cerilliant Introduces Snap-N-Spike® Stable-Labeled Internal Standards of Antifungal Agents	PR
04/06/15	Sigma Aldrich : Expands Analytical Portfolio with National Institute of Standards and Technology Standard Reference Materials	PR
02/06/15	Sigma Aldrich : to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells	PR
12/05/15	Sigma Aldrich : SAFC Completes ADC Commercial Manufacturing Capacity Expansion in St. Louis	PU
12/05/15	Sigma Aldrich : SAFC Expands Carlsbad, Calif. Facility to Support Commercial-Scale Gene Therapy Production, Testing and Filling	PR
07/05/15	Sigma Aldrich : NASDAQ - SIAL) Reports Q1 2015 Sales Of $676 Million And Adjusted Diluted EPS Of $1.06. Declares $0.23 Quarterly Dividend.	PR